Contact | Sitemap | About Medicines Research Responsibility News Investors Careers During 2014, Gilead's medicines helped more patients than ever before. Video Link Online Annual Review Read transcript HIV / AIDS Liver Diseases Hematology / Oncology Cardiovascular Inflammation / Respiratory Other Therapies HIV / AIDS Gilead plays a central role in developing single tablet regimens – with one pill once a day, patients can take all of their medication in each dose. Product Info Pipeline Info Accessing Treatment for Chronic Hepatitis C Gilead has made it a priority to help ensure worldwide access to its first-in-class treatment for hepatitis C. Learn more. Second Quarter 2015 Financial Results Access earnings press release, webcast link and slides for Gilead’s second quarter 2015 results. View materials. News Events November 13, 2015 through November 18, 2015 American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting 2015 About Gilead Leadership Worldwide Operations Ethics Business Conduct Business Partnerships Corporate History Timeline Research Pipeline Clinical Trials Investigator Sponsored Research Medicines Request Information Consumer Product Safety Authorized Distributors of Record Product Approval Timeline Responsibility U.S. Patient Access Developing World Access Corporate Contributions Policy Perspectives Gilead Foundation News Press Releases Events Media FAQs Fact Sheets Media Inquiries Investors Recent News Corporate Governance Stock Information Financial Information SEC Filings Shareholder Center Annual Reports Email Alerts Investor FAQs Investor Contacts Investor Disclaimer Careers Open Positions Worldwide North America South America Europe Africa Asia Australia Internship Opportunities Culture and Values U.S. Benefits © 2009-2013 Gilead. All rights reserved. Terms of Use | Privacy Statements Product images shown do not represent actual size.